β-blockers and the treatment of hypertension

Journal of Hypertension

Volumn 25, Issue 7, 2007, Pages 1351-1353

  Williams, Bryan ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; CLINICAL PRACTICE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DRUG EFFICACY; DRUG FATALITY; DRUG INDICATION; EDITORIAL; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; STROKE; UNSTABLE ANGINA PECTORIS;

EID: 34250335186     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328182266a     Document Type: Editorial

References (15)

1. Messerli FH, Grossman E, Goldbourt U. Are β-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA 1998; 278:1903-1907.
2. Carlberg B, Samuelsson O, Lindholm LH. Atenolol in hypertension: is it a wise choice? Lancet 2004; 364:1684-1689.
3. Lindholm LH, Carlberg B, Samuelsson O. Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005; 366:1545-1553.
4. Wiysonge C, Bradley H, Myose B, Maroni R, Mbewu A, Opie L, Volmink J. Beta-blockers for hypertension. Cochrane Data Base Syst Rev 2007; 1:CD002003.
5. Blackburn DF, Lamb DA, Eurich DT, Johnson JA, Wilson TW, Dobson RT, Blackburn JL. Atenolol as initial antihypertensive therapy: An observational study comprin first line agents. J Hypertens 2007; 25:1499-1505.
6. Dahlof B, Devereaux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al., for the LIFE study group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359:995-1003.
7. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al., for the ASCOT investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366:895-906.
8. Mason JM, Dickenson HO, Nicholson DJ, Campbell F, FordG A, Williams B. The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension. J Hypertens 2005; 10:1777-1781.
9. NICE/BHS. Clinical guideline 34: hypertension. Management of hypertension in adults in primary care: partial update. http://www.nice.org.uk/CG034guidance [accessed 10 March 2007].
10. Furburg CD, Psaty BM. Calcium antagonists: not appropriate as first line antihypertensive agents. Am J Hypertens 1996; 9:122-125.
11. Cutler JA. Calcium-channel blockers for hypertension - uncertainty continues. N Engl J Med 1998; 338:679-681.
12. Kaplan RC, Heckbert SR, Koepsell TD, Rosendaal FR, Psaty BM. Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding. Arch Intern Med 2000; 160:1849-1855.
13. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: the Antihypertensive and Lipid Lowering treatment to prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-2997.
14. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al., for the VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363:2022-2031.
15. Williams B. Evolution of hypertensive disease: a revolution in guidelines. Lancet 2007; 368:6-9.